With more than 258.1 million total doses of the COVID-19 vaccine and an estimated 40 million flu vaccinations seasonally dispensed at retail pharmacies, U.S. consumers have grown accustomed to—and very comfortable with—the idea of receiving health services at their local pharmacies. According to the J.D. Power 2022 U.S. Pharmacy Study,SM released today, the evolution toward health and wellness services—in addition to medication management—may be the key to the future of the retail pharmacy industry as it contends with growing threats from online retailers.
“Customers are beginning to embrace their retail pharmacy as a hub for a broad range of routine health and wellness services,” said Christopher Lis, managing director, global healthcare intelligence at J.D. Power. “This transformation is happening simultaneously with rising competition from online retailers such as Amazon, which is raising the stakes for local retail pharmacies. This is an opportunity for more retail pharmacies to innovate as a one-stop shop for routine care and to leverage data and technology to create an increasingly personalized customer experience.”
Click here to read the full press release, including key findings from the study and brand rankings.